Couts KL, Turner JA, Bemis J, et al. Actionable kinase fusions are frequent in pan-negative melanomas. SMR 2017, abstract SMR06-5.
Etoposide-cisplatine versus irinotecan-cisplatine bij gevorderde gastro-intestinale NEC
jan 2023 | Maag-darm-leveroncologie